Values First Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Values First Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-7,844	Closed	-$988K	–	168
2023 Q4	$988K	Sell	7,844 -2,391	-23%	-$238K	0.6%	50
2023 Q3	$958K	Buy	10,235 +314	+3%	+$29.4K	0.62%	48
2023 Q2	$885K	Buy	9,921 +2,517	+34%	+$219K	0.53%	53
2023 Q1	$794K	Buy	7,404 +150	+2%	+$17.2K	0.51%	57
2022 Q4	$886K	Sell	7,254 -1,973	-21%	-$229K	0.62%	50
2022 Q3	$953K	Sell	9,227 -3,302	-26%	-$313K	0.68%	49
2022 Q2	$1.17M	Sell	12,529 -1,536	-11%	-$145K	0.83%	39
2022 Q1	$1.65M	Buy	14,065 +4,056	+41%	+$470K	1.04%	32
2021 Q4	$1.35M	Sell	10,009 -3,859	-28%	-$574K	0.8%	40
2021 Q3	$2.21M	Buy	13,868 +2,877	+26%	+$394K	1.43%	20
2021 Q2	$1.45M	Buy	10,991 +652	+6%	+$86.9K	0.98%	37
2021 Q1	$1.33M	Buy	10,339 +2,023	+24%	+$307K	0.98%	37
2020 Q4	$1.39M	Buy	8,316 +755	+10%	+$125K	1.11%	34
2020 Q3	$1.17M	Sell	7,561 -228	-3%	-$32.8K	1.07%	32
2020 Q2	$1.15M	Sell	7,789 -539	-6%	-$74K	1.14%	33
2020 Q1	$938K	Sell	8,328 -1,995	-19%	-$259K	1.13%	39
2019 Q4	$1.44M	Buy	+10,323	New	+$1.15M	1.39%	24

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Values First Advisors's ASND Position: Q1 2024 in Review

Values First Advisors sold out of Ascendis Pharma A/S (ASND) in Q1 2024, closing a stake of 7,844 shares — an estimated $988K sold.

Values First Advisors first reported a position in ASND in Q4 2019 and held it in 17 quarters. The position peaked at $2.21M in Q3 2021. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

Values First Advisors reported no remaining Ascendis Pharma A/S position as of Q1 2024 after selling out during the quarter.
Values First Advisors sold 7,844 Ascendis Pharma A/S shares in Q1 2024, an estimated $988K.
Values First Advisors first reported a position in Ascendis Pharma A/S in Q4 2019 and held it in 17 quarters.
Values First Advisors's Ascendis Pharma A/S position peaked at $2.21M in Q3 2021.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on Values First Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.